Officer sold
~$1.12MReported value · 1,758 sh @ $634.5718
Stock since the trade -18.5% · S&P 500 +12.3% · to Oct 1
Idexx Laboratories's Executive Vice President sold $1.12M of Idexx Laboratories shares. Nobody planned it ahead of time.
Loading…
Reporting person on SEC Form 4
Nimrata Hunt
Executive Vice President
Disclosures on record
25
Companies involved
1
Disclosure history
Officer sold
~$1.78MReported value · 2,693 sh @ $661.5413
Stock since the trade -21.6% · S&P 500 +10.8% · to Oct 1
Idexx Laboratories's Executive Vice President sold $1.78M of Idexx Laboratories shares. Nobody planned it ahead of time.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Officer sold
~$3.59MReported value · 5,114 sh @ $702.2017
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1
Idexx Laboratories's Executive Vice President sold $3.59M of Idexx Laboratories shares. Nobody planned it ahead of time.
Officer sold
~$1.03MReported value · 1,468 sh @ $704.8659
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1
Idexx Laboratories's Executive Vice President sold $1.03M of Idexx Laboratories shares. Nobody planned it ahead of time.
Officer sold
~$1.03MReported value · 1,465 sh @ $703.7339
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1
Idexx Laboratories's Executive Vice President sold $1.03M of Idexx Laboratories shares. Nobody planned it ahead of time.
Officer sold
~$972KReported value · 1,378 sh @ $705.5448
Stock since the trade -26.9% · S&P 500 +13.9% · to Oct 1
Idexx Laboratories's Executive Vice President sold $972K of Idexx Laboratories shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.